Shenzhen Chipscreen Biosciences Co., Ltd. (SHA:688321)
China · Delayed Price · Currency is CNY 25.18
-0.11 (-0.43%)
Sep 4, 2026, 3:00 PM CST
SHA:688321 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,047 | 910.06 | 657.95 | 523.71 | 529.94 | 430.45 |
Revenue Growth | 37.29% | 38.32% | 25.63% | -1.18% | 23.11% | 59.74% |
Gross Profit Gross Profit Growth | 929.46 | 792.83 | 570.48 | 466.74 | 499.95 | 408.87 |
Operating Income Operating Income Growth | 129.98 | 85.32 | -60.6 | -183.87 | 5.82 | -13.04 |
Net Income Net Income Growth | 92.75 | 50.96 | -114.57 | 88.84 | 17.48 | 21.96 |
Earnings Per Share EPS Growth | 0.22 | 0.13 | -0.28 | 0.22 | 0.04 | 0.05 |
EPS Growth | - | - | - | 406.05% | -19.78% | -29.20% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
South China South China Growth | 274.58 |
North China North China Growth | 122.55 |
East China East China Growth | 251.65 |
Southwest Region Southwest Region Growth | 110.68 |
Northwest Northwest Growth | 28.05 |
Central China Central China Growth | 79.36 |
Northeast China Northeast China Growth | 26.31 |
Taiwan Taiwan Growth | 0.54 |
America America Growth | 2.11 |
Total Total Growth | 895.83 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,514 | 643.05 | 469.69 | 850.14 | 981.65 | 482.71 |
Total Debt Total Debt Growth | 1,544 | 1,546 | 1,334 | 1,078 | 807.87 | 149.14 |
Net Cash (Debt) Net Cash Growth | -29.37 | -903.19 | -863.9 | -228.24 | 173.78 | 333.58 |
Net Cash Growth | - | - | - | - | -47.90% | -48.17% |
Net Cash Per Share Net Cash Per Share Growth | -0.07 | -2.22 | -2.12 | -0.56 | 0.43 | 0.81 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | - | 96.97 | 76.13 | -157.27 | 43.3 | 124.78 |
Capital Expenditures CapEx Growth | - | -178.6 | -268.49 | -229.03 | -400.17 | -288.46 |
Free Cash Flow Free Cash Flow Growth | - | -81.64 | -192.36 | -386.3 | -356.87 | -163.68 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 88.80% | 87.12% | 86.71% | 89.12% | 94.34% | 94.99% |
Operating Margin | 12.42% | 9.38% | -9.21% | -35.11% | 1.10% | -3.03% |
Pretax Margin | 9.05% | 5.50% | -14.70% | 18.53% | 2.86% | 4.32% |
Profit Margin | 8.86% | 5.60% | -17.41% | 16.96% | 3.30% | 5.10% |
FCF Margin | - | -8.97% | -29.24% | -73.76% | -67.34% | -38.03% |
| Fiscal Year | Current | FY 2025 |
|---|---|---|
| Period Ending | Sep '26 Sep 6, 2026 | Dec '25 Dec 31, 2025 |
Dividend Per Share Dividend Per Share Growth | 0.058 | 0.058 |
Dividend Per Share Growth | 0% | - |
Dividend Yield | 0.23% | 0.20% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 114.25 | 233.84 | - | 100.69 | 511.60 | 654.85 |
Forward PE | - | 262.00 | 262.00 | 94.41 | 114.18 | 160.97 |
PS Ratio | 10.64 | 13.09 | 11.52 | 17.08 | 16.88 | 33.41 |